XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock At Cost [Member]
Accumulated Other Comprehensive Loss [Member]
Retained Earnings (Accumulated Deficit) [Member]
Total
Balance at Feb. 02, 2019 $ 32 $ 344,826 $ (230,166) $ (735) $ (50,227) $ 63,730
Balance (in shares) at Feb. 02, 2019 3,222   (1,409)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 (39,085) (39,085) [1]
Other comprehensive income 0 0 0 15 0 15
Vested restricted shares $ 0 3 $ (2) 0 0 1
Vested restricted shares (in shares) 4   0      
Amortization of unearned compensation/restricted stock amortization $ 0 214 $ 0 0 0 214
Balance at Nov. 02, 2019 $ 32 345,043 $ (230,168) (720) (89,312) 24,875
Balance (in shares) at Nov. 02, 2019 3,226   (1,409)      
Balance at Aug. 03, 2019 $ 32 344,983 $ (230,168) (725) (66,157) 47,965
Balance (in shares) at Aug. 03, 2019 3,224   (1,409)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 (23,155) (23,155)
Other comprehensive income 0 0 0 5 0 5
Vested restricted shares $ 0 0 $ 0 0 0 0
Vested restricted shares (in shares) 2   0      
Amortization of unearned compensation/restricted stock amortization $ 0 60 $ 0 0 0 60
Balance at Nov. 02, 2019 $ 32 345,043 $ (230,168) (720) (89,312) 24,875
Balance (in shares) at Nov. 02, 2019 3,226   (1,409)      
Balance at Feb. 01, 2020 $ 32 345,102 $ (230,169) (1,479) (108,971) 4,515
Balance (in shares) at Feb. 01, 2020 3,226   (1,409)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 (3,753) (3,753)
Other comprehensive income 0 0 0 9 0 9
Issuance of warrants 0 836 0 0 0 836
Vested restricted shares $ 0 (9) $ 0 0 0 (9)
Vested restricted shares (in shares) 4   (1)      
Common stock issued- Director/new grants $ 0 243 $ 0 0 0 243
Common stock issued- Director/new grants (in shares) 6   0      
Amortization of unearned compensation/restricted stock amortization $ 0 298 $ 0 0 0 298
Balance at Oct. 31, 2020 $ 32 346,470 $ (230,169) (1,470) (112,724) 2,139
Balance (in shares) at Oct. 31, 2020 3,236   (1,410)      
Balance at Aug. 01, 2020 $ 32 346,457 $ (230,169) (1,473) (115,276) (430)
Balance (in shares) at Aug. 01, 2020 3,236   (1,410)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 2,552 2,552
Other comprehensive income 0 0 0 3 0 3
Amortization of unearned compensation/restricted stock amortization 0 13 0 0 0 13
Balance at Oct. 31, 2020 $ 32 $ 346,470 $ (230,169) $ (1,470) $ (112,724) $ 2,139
Balance (in shares) at Oct. 31, 2020 3,236   (1,410)      
[1] The cash flows related to discontinued operations have not been segregated, and are included in the Consolidated Statements of Cash Flows. See footnote 3.